Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Dopamine
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==History and development== {{Main|History of catecholamine research}} Dopamine was first synthesized in 1910 by [[George Barger]] and James Ewens at [[Wellcome Trust|Wellcome]] Laboratories in London, England<ref name="pmid18781671">{{cite journal | vauthors = Fahn S | title = The history of dopamine and levodopa in the treatment of Parkinson's disease | journal = Movement Disorders | volume = 23 | issue = Suppl 3 | pages = S497–508 | year = 2008 | pmid = 18781671 | doi = 10.1002/mds.22028 | s2cid = 45572523 }}</ref> and first identified in the human brain by [[Katharine Montagu]] in 1957. It was named dopamine because it is a [[monoamine]] whose precursor in the Barger-Ewens synthesis is 3,4-'''d'''ihydr'''o'''xy'''p'''henyl'''a'''lanine (levodopa or L-DOPA). Dopamine's function as a neurotransmitter was first recognized in 1958 by [[Arvid Carlsson]] and [[Nils-Åke Hillarp]] at the Laboratory for Chemical Pharmacology of the National Heart Institute of [[Sweden]].<ref name="pmid11165672">{{cite journal | vauthors = Benes FM | title = Carlsson and the discovery of dopamine | journal = Trends in Pharmacological Sciences | volume = 22 | issue = 1 | pages = 46–47 | date = January 2001 | pmid = 11165672 | doi = 10.1016/S0165-6147(00)01607-2 }}</ref> Carlsson was awarded the 2000 [[Nobel Prize in Physiology or Medicine]] for showing that dopamine is not only a precursor of norepinephrine (noradrenaline) and epinephrine (adrenaline), but is also itself a neurotransmitter.<ref name=Barondes>{{cite book| vauthors = Barondes SH | year=2003| title=Better Than Prozac| pages=[https://archive.org/details/betterthanprozac00baro/page/21 21–22, 39–40]| location=New York| publisher=Oxford University Press| isbn=978-0-19-515130-5| url-access=registration| url=https://archive.org/details/betterthanprozac00baro/page/21}}</ref> ===Polydopamine=== Research motivated by [[bioadhesive|adhesive]] [[polyphenolic protein]]s in [[mussel]]s led to the discovery in 2007 that a wide variety of materials, if placed in a solution of dopamine at slightly basic [[pH]], will become coated with a layer of polymerized dopamine, often referred to as '''polydopamine'''.<ref>{{cite journal | vauthors = Lee H, Dellatore SM, Miller WM, Messersmith PB | title = Mussel-inspired surface chemistry for multifunctional coatings | journal = Science | volume = 318 | issue = 5849 | pages = 426–30 | date = October 2007 | pmid = 17947576 | pmc = 2601629 | doi = 10.1126/science.1147241 | bibcode = 2007Sci...318..426L }}</ref><ref name=Dreyer>{{cite journal | title = Perspectives on poly(dopamine) | vauthors = Dreyer DR, Miller DJ, Freeman BD, Paul DR, Bielawski CW | journal = Chemical Science | year = 2013 | doi = 10.1039/C3SC51501J | volume=4 | issue = 10 | page=3796}}</ref> This polymerized dopamine forms by a spontaneous oxidation reaction, and is formally a type of melanin.<ref name=Lynge>{{cite journal | vauthors = Lynge ME, van der Westen R, Postma A, Städler B | title = Polydopamine—a nature-inspired polymer coating for biomedical science | journal = Nanoscale | volume = 3 | issue = 12 | pages = 4916–28 | date = December 2011 | pmid = 22024699 | doi = 10.1039/c1nr10969c | url = https://www.researchgate.net/publication/51742922 | archive-url = https://web.archive.org/web/20140307205318/http://www.researchgate.net/profile/Almar_Postma/publication/51742922_Polydopamine--a_nature-inspired_polymer_coating_for_biomedical_science/file/d912f50318c9e0c7bb.pdf | bibcode = 2011Nanos...3.4916L | archive-date = 7 March 2014 }}</ref> Furthermore, dopamine self-polymerization can be used to modulate the mechanical properties of peptide-based gels.<ref>{{cite journal | vauthors = Fichman G, Schneider JP | title = Dopamine Self-Polymerization as a Simple and Powerful Tool to Modulate the Viscoelastic Mechanical Properties of Peptide-Based Gels | journal = Molecules | volume = 26 | issue = 5 | pages = 1363 | date = March 2021 | pmid = 33806346 | pmc = 7961423 | doi = 10.3390/molecules26051363 | doi-access = free }}</ref> Synthesis of polydopamine usually involves reaction of dopamine hydrochloride with [[Tris]] as a base in water. The structure of polydopamine is unknown.<ref name=Dreyer /> Polydopamine coatings can form on objects ranging in size from [[nanoparticle]]s to large surfaces.<ref name=Lynge/> Polydopamine layers have chemical properties that have the potential to be extremely useful, and numerous studies have examined their possible applications.<ref name=Lynge/> At the simplest level, they can be used for protection against damage by light, or to form capsules for drug delivery.<ref name=Lynge/> At a more sophisticated level, their adhesive properties may make them useful as substrates for [[biosensor]]s or other biologically active macromolecules.<ref name=Lynge/>
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Dopamine
(section)
Add topic